Public Trust Board Meeting Papers Date: 27 September 2018

Public Trust Board Meeting Papers Date: 27 September 2018

Public Trust Board Meeting Papers Date: 27 September 2018 Time: 11:00 – 13:00 Venue: Conference Room, Trust Headquarters 1 2 BOARD OF DIRECTORS (in Public) Meeting to be held in Public Thursday 27 September 2018, 11.00 – 13.00 Conference Room, Trust HQ, Marlborough St, Bristol, BS1 3NU AGENDA NO. AGENDA ITEM PURPOSE SPONSOR PAGE NO. Preliminary Business 1. Apologies for absence Information Chair Verbal 2. Declarations of interest Information Chair Verbal 3. Patient Story Assurance Chief Executive 7 4. Minutes of the last meeting Approval Chair 11 • 27 July 2018 5. Matters arising and action log Approval Chair 27 6. Chief Executive’s Report Information Chief Executive 29 Care and Quality 7. Review of Major Incident in Approval Chief Executive 35 the Bristol Haematology And Oncology Centre in May 2018 8. Quality and Performance Assurance Deputy Chief 57 Report Executive and Chief Operating Officer; Chief Nurse/Medical Director 9. Quality and Outcomes Assurance Quality and Committee Chair’s Report Outcomes • August Committee Chair 59 • September To be tabled 10. Six-Monthly Nurse Staffing Assurance Chief Nurse 63 Report 11. Patient Complaints and Chief Nurse Experience Reports a) Patient Complaints Q1 Assurance 71 Report b) Patient Experience Q1 Information 115 Report 12. Evaluation of Patient Safety Assurance Chief Nurse 143 Programme 2015-2018 and Patient Safety Priorities 2019- 3 NO. AGENDA ITEM PURPOSE SPONSOR PAGE NO. 2021 13. Learning from Deaths Report Assurance Medical Director 239 14. Infection Prevention and Assurance Chief Nurse 245 Control Annual Report 2017/2018 Workforce 15. Revalidation and Medical Assurance Medical Director 265 Appraisal Report Strategy and Transformation 16. Healthier Together Information Chief Executive 281 Sustainability and Transformation Partnership Update Financial Performance 17. Finance Report Information Director of Finance 297 and Information 18. Finance Committee Chair’s Assurance Chair of Finance Report Committee • August 315 • September To be tabled 19. Strategic Capital Programme Approval Director of Finance 317 and Medium Term Financial and Information; Plan Director of Strategy and Transformation Governance 20. Well-led Review Self- Decision Trust Secretary 345 Assessment 21. Governors’ Expenses Policy Approval Trust Secretary 355 Review 22. Board Evaluation Decision Trust Secretary 371 23. Committee Terms of Decision Trust Secretary 386 Reference – Strategic Review Items for Information 24. Governors’ Log of Assurance Chief Executive 394 Communications Concluding Business 4 NO. AGENDA ITEM PURPOSE SPONSOR PAGE NO. 25. Any Other Urgent Business Chair Verbal 26. Date and time of next meeting Chair Verbal • 29 November 2018, 11.00 – 13.00, Trust HQ 5 6 Cover report to the Public Trust Board. Meeting to be held on 27 September 2018 at 11.00 – 13.00, Conference Room, Trust HQ, Marlborough St, Bristol, BS1 3NU Agenda Item 3 Meeting Title Public Trust Board Meeting Date Thursday, 27 September 2018 Report Title Patient Story Author Tony Watkin, Patient and Public Involvement Lead Executive Lead Carolyn Mills, Chief Nurse Freedom of Information Status Open Strategic Priorities (please chose any which are impacted on / relevant to this paper) Strategic Priority 1: We will consistently ☒ Strategic Priority 5: We will provide leadership to ☒ deliver high quality individual care, the networks we are part of, for the benefit of the delivered with compassion services. region and people we serve. Strategic Priority 2: We will ensure a ☐ Strategic Priority 6: We will ensure we are ☐ safe, friendly and modern environment financially sustainable to safeguard the quality of for our patients and our staff. our services for the future and that our strategic direction supports this goal. Strategic Priority 3: We will strive to ☐ Strategic Priority 7: We will ensure we are soundly ☐ employ the best staff and help all our governed and are compliant with the requirements staff fulfil their individual potential . of NHS Improvement. Strategic Priority 4: We will deliver ☐ ☐ pioneering and efficient practice, putting ourselves at the leading edge of research, innovation and transformation Action/Decision Required (please select any which are relevant to this paper) For Decision ☐ For Assurance ☒ For Approval ☐ For Information ☒ Executive Summary Purpose Patient stories reveal a great deal about the quality of our services, the opportunities we have for learning, and the effectiveness of systems and processes to manage, improve and assure quality. The purpose of presenting a patient story to Board members is: To set a patient-focussed context for the meeting. For Board members to understand the impact of the lived experience for this patient and for Board members to reflect on what the experience reveals about our staff, morale and organisational culture, quality of care and the context in which clinicians work. 7 Key issues to note At this meeting we had intended to share a story from a family member and carer of a patient in their 70s who is receiving care at the Bristol Haematology and Oncology Hospital (BHOC) This was as an alternative to original plans to share a patient support story from the Trust’s Volunteer Services. The story was to have charted a 12 month journey through BHOC from initial diagnosis to on- going care with a particular focus on the emotions and feelings experienced by the family member (the patient’s son) as they cared for and provided support to their loved one (the family members father). The story encapsulates the highs and lows, joys and tensions of being a family member with carer responsibilities and sheds light on the value we place on carers and the role they have as partners in care. Unfortunately, at short notice, the family member has had to withdraw from sharing their experience with the Board yet remains committed to doing so at a future meeting. They asked me to extend their apologies and inform you that both they and their loved one are doing well. Attempts are being made by the Patient Experience and Involvement team to secure an alternative patient story although this is proving difficult. Looking ahead, plans are in place for the Board to receive a patient story from the Teenage and Young Adult Cancer Services in November. Recommendations Members are asked to: Note the patient story Intended Audience (please select any which are relevant to this paper) Board/Committee ☒ Regulators ☐ Governors ☐ Staff ☐ Public ☐ Members Board Assurance Framework Risk (please choose any which are impacted on / relevant to this paper) Failure to maintain the quality of patient ☐ Failure to develop and maintain the Trust ☐ services. estate. Failure to act on feedback from patients, ☒ Failure to recruit, train and sustain an ☐ staff and our public. engaged and effective workforce. Failure to enable and support ☐ Failure to take an active role in working ☐ transformation and innovation, to embed with our partners to lead and shape our research and teaching into the care we joint strategy and delivery plans, based provide, and develop new treatments for on the principles of sustainability, the benefit of patients and the NHS. transformation and partnership working. Failure to maintain financial ☐ Failure to comply with targets, statutory ☐ sustainability. duties and functions. Corporate Impact Assessment (please tick any which are impacted on / relevant to this paper) Quality ☐ Equality ☒ Legal ☐ Workforce ☐ 8 Impact Upon Corporate Risk N/A Resource Implications (please tick any which are impacted on / relevant to this paper) Finance ☐ Information Management & Technology ☐ Human Resources ☐ Buildings ☐ Date papers were previously submitted to other committees Audit Finance Quality and Remuneration Other (specify) Committee Committee Outcomes & Nomination Committee Committee 9 10 Minutes of the Board of Directors Meeting Held in Public on Friday 27 July 2018, 11:00-13:00, Conference Room, Trust Headquarters Present Board Members Member Name Job Title/Position Jeff Farrar Chair of the Board David Armstrong Non-Executive Director Madhu Bhabuta Non-Executive Director (Designate) Mark Callaway Acting Medical Director Paula Clarke Director of Strategy and Transformation Julian Dennis Non-Executive Director Matt Joint Director of People Paul Mapson Director of Finance and Information Carolyn Mills Chief Nurse John Moore Non-Executive Director Mark Smith Deputy Chief Executive and Chief Operating Officer Martin Sykes Non-Executive Director Jill Youds Non-Executive Director In Attendance Name Job Title/Position Sophie Melton Bradley Deputy Trust Secretary William Oldfield Medical Director (Designate) Kate Parraman Deputy Director of Finance Jeanette Jones Royal College of Nursing Lead, Joint Union Committee John Kirk Communications Manager Alistair Johnstone Consultant Anaesthetist and Safe Working Hours Guardian Mark Read Chaplaincy Team Leader (for item 2) Lisa Smith LIASE Support Officer (for item 2) Mo Phillips Public Governor Malcolm Watson Public Governor John Rose Public Governor Rashid Joomun Patient Governor Garry Williams Patient/Carer Governor Florene Jordan Staff Governor Andy Coles-Driver Staff Governor Emma King Member of the public Minutes: Sarah Murch: Membership and Governance Administrator The Chair opened the Meeting at 11.00 Minute Ref Item Number Action 11 Minute Ref Item Number Action Preliminary Business 120/07/2018 1. Welcome and Introductions/Apologies for Absence The Chair, Jeff Farrar, welcomed everyone to the meeting. Apologies were received from Chief Executive

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    446 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us